Skip to content

mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation

An mHealth Mood Management Tool to Improve Population-Level Cessation

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04525222
Enrollment
242
Registered
2020-08-25
Start date
2022-05-09
Completion date
2023-04-12
Last updated
2024-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking-Related Carcinoma

Brief summary

This phase I trial investigates a new smartphone application (called Actify) for improving population-level smoking cessation and mood management. Actify delivers behavioral activation therapy for depression as part of a smoking cessation intervention and will be compared to another smoking cessation smartphone application that is based on current clinical practice guidelines. Participants will be randomly assigned to receive one of two smartphone applications and accompanying text notifications to help with quitting smoking and improved mood.

Detailed description

OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants use Actify app for smoking cessation for 8 weeks. Participants also receive motivational messages and smoking cessation information via text notifications. ARM II: Participants use United States (US) Clinical Practice Guidelines (USCPG) app for smoking cessation for 8 weeks. Participants also receive motivational messages and smoking cessation information via text notifications. After completion of study, participants are followed up at 6 months.

Interventions

OTHERHealth Promotion and Education

Receive motivational messages and smoking cessation information via text notifications

BEHAVIORALSmoking Cessation Intervention (Actify app)

Use Actify app

BEHAVIORALSmoking Cessation Intervention (Current Standard Care app)

Use (USCPG) Current Standard Care app

OTHERSurvey Administration

Ancillary studies

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Any outcome evaluator who has direct contact with participants will be blinded to treatment group assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Current smoker, averaging at least 5 cigarettes/day for the last 30 days * Interested in quitting smoking in the next 30 days * Experience downloading and using one or more apps on their smartphone * Either screens negative (Patient Health Questionnaire - 9 Item \[PHQ-9\] score 0-4) for depression or screens positive for mild to moderate current depressive symptoms (PHQ-9 score 5-19) * Willing and able to complete all study activities * Comfortable reading and writing in English * Have a mobile data plan and/or access to WiFi to support the use of the Actify app * Reside in the US * Have a smartphone either an iPhone (running iOS version 11 or higher) or an Android phone (running version 5.0 or higher)

Exclusion criteria

* Currently receiving behavioral treatment for depression (e.g., psychotherapy) * Current use of a depression app * Severe depression (PHQ-9 \>= 20) * Receiving other treatment for smoking cessation * Previous use of the QuitGuide app * Current or recent (within the past year) enrollment in a Fred Hutch smoking cessation study * Employees/family of investigator or study center * Member of the same household as another participant * Woman who is pregnant or breastfeeding, or planning to become pregnant * Currently incarcerated * Is ineligible per fraud prevention protocol

Design outcomes

Primary

MeasureTime frameDescription
Overall Satisfaction With Assigned Treatment on the Treatment Satisfaction SurveyAt 8 weeks post-randomizationOverall treatment satisfaction is reported on a Likert-type scale, with response choices ranging from not at all=1 to very much=5. Higher values are associated with higher level of satisfaction.
Application (App) UtilizationAt 8 weeks post-randomizationNumber of app openings during the 8-week treatment period.

Secondary

MeasureTime frameDescription
Self-reported 7-day PPA From SmokingAt 8 weeks post-randomizationSelf-reported 7-day abstinence on the survey question of When was the last time you smoked, or even tried, a cigarette?
Biochemically Confirmed 7-day PPA From SmokingAt 8 weeks post-randomizationSelf-reported 7-day abstinence from smoking, confirmed via expired carbon monoxide (CO \< 6ppm)
Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesAt 8 weeks post-randomizationSelf-reported 30-day abstinence on the survey questions of Have you smoked at all, even a puff, in the last 30 days? & In the last 30 days, how often did you use any kind of e-cigarette or vaping product? & In the last 30 days, how often did you use any other tobacco products such as chewing tobacco, snus, hookahs, cigars, cigarillos, tobacco pipes, and kreteks?
Biochemically-confirmed 30-day PPA From SmokingAt 8 weeks post-randomizationSelf-reported 30-day smoking abstinence at 8 weeks, confirmed via expired carbon monoxide (CO\<6ppm)
Change in Depressive Symptoms Via Patient Health Questionnaire-8 (PHQ-8)Baseline to 8 weeksThe Patient Health Questionnaire-8 (PHQ-8) is an assessment of depressive symptoms used to detect symptom changes over time as a result of treatment. The PHQ-8 asks the number of days in the past 2 weeks the respondent had experienced a particular depressive symptom. Possible answers are not at all or several days or more than half the days or nearly every day, with points (0 to 3) assigned to each category. The scores for each item are summed to produce a total score between 0 and 24 points. A total score of 0 to 4 represents no significant depressive symptoms. A total score of 5 to 9 represents mild depressive symptoms; 10 to 14, moderate; 15 to 19, moderately severe; and 20 to 24, severe.
Self-reported 30-day Point Prevalence Abstinence (PPA) From SmokingAt 8 weeks post-randomizationSelf-reported 30-day abstinence on the survey question of Have you smoked at all, even a puff, in the last 30 days?
Change in Behavioral Activation Subscale Score on the Behavioral Activation for Depression Scale (BADS)Baseline to 8 weeks post-randomizationThe Behavioral Activation for Depression Scale (BADS) is a 25-item scale used to track changes in behaviors hypothesized to underlie depression and specifically targeted for change by behavioral activation. BADS items are rated on a 7-point scale ranging from 0 (not at all) to 6 (completely). The behavioral activation subscale contains 7 items, with a scoring range of 0 to 42. Change scores reflect the value of the BADS behavioral activation subscale score at 8-week follow-up minus the baseline score. Positive change values indicate an increase in behavioral activation (i.e, an improvement), whereas negative scores indicate a decrease in behavioral activation.
Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesAt 8 weeks post-randomizationSelf-reported abstinence from cigarettes and other non-medicinal nicotine/tobacco products, including e-cigarettes, confirmed via at home saliva cotinine test and expired carbon monoxide (CO \< 6ppm)
Self-reported 30-day PPA From SmokingAt 6 months post-randomizationSelf-reported 30-day abstinence on the survey question of Have you smoked at all, even a puff, in the last 30 days?

Countries

United States

Participant flow

Recruitment details

Two-hundred forty two participants were eligible and enrolled in the study. The final sample comprised 242 participants who were randomized between May 9, 2022 and September 30, 2022.

Participants by arm

ArmCount
Arm I (Actify, Text Notifications)
Participants use Actify app for smoking cessation for 8 weeks. Participants also receive motivational messages and smoking cessation information via text notifications. Health Promotion and Education: Receive motivational messages and smoking cessation information via text notifications Smoking Cessation Intervention (Actify app): Use Actify app Survey Administration: Ancillary studies
119
Arm II (Current Standard Care, Text Notifications)
Participants use app for smoking cessation for 8 weeks. Participants also receive motivational messages and smoking cessation information via text notifications. Health Promotion and Education: Receive motivational messages and smoking cessation information via text notifications Smoking Cessation Intervention (Current Standard Care app): Use (USCPG) Current Standard Care app Survey Administration: Ancillary studies
123
Total242

Baseline characteristics

CharacteristicArm I (Actify, Text Notifications)TotalArm II (Current Standard Care, Text Notifications)
Age, Continuous48.5 years
STANDARD_DEVIATION 11
50.3 years
STANDARD_DEVIATION 10.5
52 years
STANDARD_DEVIATION 9.8
Cigarettes per Day in the past 30 days)18 cigarettes per day
STANDARD_DEVIATION 7.7
19.1 cigarettes per day
STANDARD_DEVIATION 10.9
20.2 cigarettes per day
STANDARD_DEVIATION 13.2
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants13 Participants6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
112 Participants229 Participants117 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Mental Health Condition - Anxiety, Depression, Bipolar, Schizophrenia, Alcohol or Drug Abuse23 Participants57 Participants34 Participants
No Mental Health Condition96 Participants185 Participants89 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants4 Participants4 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
17 Participants38 Participants21 Participants
Race (NIH/OMB)
More than one race
2 Participants9 Participants7 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants10 Participants5 Participants
Race (NIH/OMB)
White
95 Participants181 Participants86 Participants
Sex: Female, Male
Female
83 Participants167 Participants84 Participants
Sex: Female, Male
Male
36 Participants75 Participants39 Participants
Smoking Level (in the past 30 days) - High (20+ CIgs/Day)64 Participants130 Participants66 Participants
Smoking Level (in the past 30 days) - Low (<20 Cigs/Day)55 Participants112 Participants57 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1190 / 123
other
Total, other adverse events
0 / 1190 / 123
serious
Total, serious adverse events
0 / 1190 / 123

Outcome results

Primary

Application (App) Utilization

Number of app openings during the 8-week treatment period.

Time frame: At 8 weeks post-randomization

Population: We used negative binomial regression adjusting for Treatment Arm, Sex Assigned at Birth, Baseline Level of Smoking (\<20 Cigs/ \>=20 Cigs), and Baseline Depression Severity (PHQ-8\<5 / PHQ-8\>=5) to compare number of app openings by treatment arm

ArmMeasureValue (MEAN)Dispersion
Arm I (Actify, Text Notifications)Application (App) Utilization34.3 app openingsStandard Deviation 33.7
Arm II (Current Standard Care, Text Notifications)Application (App) Utilization34.3 app openingsStandard Deviation 39.4
p-value: 0.7595% CI: [-15.22, 21.07]Negative Binomial Regression
Primary

Overall Satisfaction With Assigned Treatment on the Treatment Satisfaction Survey

Overall treatment satisfaction is reported on a Likert-type scale, with response choices ranging from not at all=1 to very much=5. Higher values are associated with higher level of satisfaction.

Time frame: At 8 weeks post-randomization

Population: Overall number of participants analyzed include those who opened the app at least once AND answered at least one acceptability question in the 8 week follow-up survey.

ArmMeasureValue (MEAN)Dispersion
Arm I (Actify, Text Notifications)Overall Satisfaction With Assigned Treatment on the Treatment Satisfaction Survey4.1 units on a scaleStandard Deviation 1
Arm II (Current Standard Care, Text Notifications)Overall Satisfaction With Assigned Treatment on the Treatment Satisfaction Survey3.7 units on a scaleStandard Deviation 1.1
Comparison: Treatment satisfaction items are reported on a Likert-type scale, with response choices ranging from not at all to very much. We used a linear regression adjusting for Treatment Arm, Sex Assigned at Birth, Baseline Level of Smoking (\<20 Cigs/ \>=20 Cigs), and Baseline Depression Severity (PHQ-8\<5 / PHQ-8\>=5) to test for differences between arms.p-value: 0.008895% CI: [0.1, 0.74]Regression, Linear
Secondary

Biochemically-confirmed 30-day PPA From Smoking

Self-reported 30-day smoking abstinence at 8 weeks, confirmed via expired carbon monoxide (CO\<6ppm)

Time frame: At 8 weeks post-randomization

ArmMeasureGroupValue (NUMBER)
Arm I (Actify, Text Notifications)Biochemically-confirmed 30-day PPA From SmokingNo Quit109 participants
Arm I (Actify, Text Notifications)Biochemically-confirmed 30-day PPA From SmokingQuit10 participants
Arm II (Current Standard Care, Text Notifications)Biochemically-confirmed 30-day PPA From SmokingNo Quit115 participants
Arm II (Current Standard Care, Text Notifications)Biochemically-confirmed 30-day PPA From SmokingQuit8 participants
p-value: 0.5595% CI: [0.5, 3.48]Regression, Logistic
Secondary

Biochemically-confirmed 30-day PPA From Smoking

Self-reported 30-day smoking abstinence at 6 months, confirmed via expired carbon monoxide (CO\<6 ppm)

Time frame: At 6 months post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Biochemically-confirmed 30-day PPA From SmokingNo Quit104 Participants
Arm I (Actify, Text Notifications)Biochemically-confirmed 30-day PPA From SmokingQuit15 Participants
Arm II (Current Standard Care, Text Notifications)Biochemically-confirmed 30-day PPA From SmokingNo Quit113 Participants
Arm II (Current Standard Care, Text Notifications)Biochemically-confirmed 30-day PPA From SmokingQuit10 Participants
p-value: 0.2595% CI: [0.7, 3.81]Regression, Logistic
Secondary

Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettes

Self-reported abstinence from cigarettes and other non-medicinal nicotine/tobacco products, including e-cigarettes, confirmed via at home saliva cotinine test and expired carbon monoxide (CO \< 6ppm)

Time frame: At 6 months post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesNo Quit107 Participants
Arm I (Actify, Text Notifications)Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesQuit12 Participants
Arm II (Current Standard Care, Text Notifications)Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesNo Quit115 Participants
Arm II (Current Standard Care, Text Notifications)Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesQuit8 Participants
p-value: 0.395% CI: [0.63, 4.19]Regression, Logistic
Secondary

Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettes

Self-reported abstinence from cigarettes and other non-medicinal nicotine/tobacco products, including e-cigarettes, confirmed via at home saliva cotinine test and expired carbon monoxide (CO \< 6ppm)

Time frame: At 8 weeks post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesNo Quit112 Participants
Arm I (Actify, Text Notifications)Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesQuit7 Participants
Arm II (Current Standard Care, Text Notifications)Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesNo Quit117 Participants
Arm II (Current Standard Care, Text Notifications)Biochemically Confirmed 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesQuit6 Participants
p-value: 0.6895% CI: [0.41, 3.86]Regression, Logistic
Secondary

Biochemically Confirmed 7-day PPA From Smoking

Self-reported 7-day abstinence from smoking, confirmed via expired carbon monoxide (CO \< 6ppm)

Time frame: At 6 months post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Biochemically Confirmed 7-day PPA From SmokingNo Quit103 Participants
Arm I (Actify, Text Notifications)Biochemically Confirmed 7-day PPA From SmokingQuit16 Participants
Arm II (Current Standard Care, Text Notifications)Biochemically Confirmed 7-day PPA From SmokingNo Quit113 Participants
Arm II (Current Standard Care, Text Notifications)Biochemically Confirmed 7-day PPA From SmokingQuit10 Participants
p-value: 0.1795% CI: [0.77, 4.12]Regression, Logistic
Secondary

Biochemically Confirmed 7-day PPA From Smoking

Self-reported 7-day abstinence from smoking, confirmed via expired carbon monoxide (CO \< 6ppm)

Time frame: At 8 weeks post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Biochemically Confirmed 7-day PPA From SmokingQuit17 Participants
Arm I (Actify, Text Notifications)Biochemically Confirmed 7-day PPA From SmokingNo Quit102 Participants
Arm II (Current Standard Care, Text Notifications)Biochemically Confirmed 7-day PPA From SmokingQuit8 Participants
Arm II (Current Standard Care, Text Notifications)Biochemically Confirmed 7-day PPA From SmokingNo Quit115 Participants
p-value: 0.0495% CI: [1, 5.85]Regression, Logistic
Secondary

Change in Behavioral Activation Subscale Score on the Behavioral Activation for Depression Scale (BADS)

The Behavioral Activation for Depression Scale (BADS) is a 25-item scale used to track changes in behaviors hypothesized to underlie depression and specifically targeted for change by behavioral activation. BADS items are rated on a 7-point scale ranging from 0 (not at all) to 6 (completely). The behavioral activation subscale contains 7 items, with a scoring range of 0 to 42. Change scores reflect the value of the BADS behavioral activation subscale score at 8-week follow-up minus the baseline score. Positive change values indicate an increase in behavioral activation (i.e, an improvement), whereas negative scores indicate a decrease in behavioral activation.

Time frame: Baseline to 8 weeks post-randomization

ArmMeasureValue (MEAN)Dispersion
Arm I (Actify, Text Notifications)Change in Behavioral Activation Subscale Score on the Behavioral Activation for Depression Scale (BADS)-2.4 score on a scaleStandard Deviation 9.6
Arm II (Current Standard Care, Text Notifications)Change in Behavioral Activation Subscale Score on the Behavioral Activation for Depression Scale (BADS).8 score on a scaleStandard Deviation 8.9
p-value: 0.002595% CI: [1.28, 5.95]Regression, Linear
Secondary

Change in Depressive Symptoms Via Patient Health Questionnaire-8 (PHQ-8)

The Patient Health Questionnaire-8 (PHQ-8) is an assessment of depressive symptoms used to detect symptom changes over time as a result of treatment. The PHQ-8 asks the number of days in the past 2 weeks the respondent had experienced a particular depressive symptom. Possible answers are not at all or several days or more than half the days or nearly every day, with points (0 to 3) assigned to each category. The scores for each item are summed to produce a total score between 0 and 24 points. A total score of 0 to 4 represents no significant depressive symptoms. A total score of 5 to 9 represents mild depressive symptoms; 10 to 14, moderate; 15 to 19, moderately severe; and 20 to 24, severe.

Time frame: Baseline to 8 weeks

Population: Follow-up score minus baseline score.

ArmMeasureValue (MEAN)Dispersion
Arm I (Actify, Text Notifications)Change in Depressive Symptoms Via Patient Health Questionnaire-8 (PHQ-8).7 units on a scaleStandard Deviation 4.2
Arm II (Current Standard Care, Text Notifications)Change in Depressive Symptoms Via Patient Health Questionnaire-8 (PHQ-8)2.2 units on a scaleStandard Deviation 5.2
p-value: 0.007295% CI: [-2.9, -0.46]Regression, Linear
Secondary

Self-reported 30-day Point Prevalence Abstinence (PPA) From Smoking

Self-reported 30-day abstinence on the survey question of Have you smoked at all, even a puff, in the last 30 days?

Time frame: At 8 weeks post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Self-reported 30-day Point Prevalence Abstinence (PPA) From SmokingNo Quit104 Participants
Arm I (Actify, Text Notifications)Self-reported 30-day Point Prevalence Abstinence (PPA) From SmokingQuit15 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 30-day Point Prevalence Abstinence (PPA) From SmokingNo Quit114 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 30-day Point Prevalence Abstinence (PPA) From SmokingQuit9 Participants
p-value: 0.17795% CI: [0.77, 4.344]Regression, Logistic
Secondary

Self-reported 30-day PPA From Smoking

Self-reported 30-day abstinence on the survey question of Have you smoked at all, even a puff, in the last 30 days?

Time frame: At 6 months post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Self-reported 30-day PPA From SmokingNo Quit97 Participants
Arm I (Actify, Text Notifications)Self-reported 30-day PPA From SmokingQuit22 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 30-day PPA From SmokingNo Quit108 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 30-day PPA From SmokingQuit15 Participants
p-value: 0.1795% CI: [0.8, 3.32]Regression, Logistic
Secondary

Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettes

Self-reported 30-day abstinence on survey questions of Have you smoked at all, even a puff, in the last 30 days? & In the last 30 days, how often did you use any kind of e-cigarette or vaping product? & In the last 30 days, how often did you use any other tobacco products such as chewing tobacco, snus, hookahs, cigars, cigarillos, tobacco pipes, and kreteks?

Time frame: At 6 months post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesQuit19 Participants
Arm I (Actify, Text Notifications)Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesNo Quit100 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesNo Quit110 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesQuit13 Participants
p-value: 0.2195% CI: [0.75, 3.46]Regression, Logistic
Secondary

Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettes

Self-reported 30-day abstinence on the survey questions of Have you smoked at all, even a puff, in the last 30 days? & In the last 30 days, how often did you use any kind of e-cigarette or vaping product? & In the last 30 days, how often did you use any other tobacco products such as chewing tobacco, snus, hookahs, cigars, cigarillos, tobacco pipes, and kreteks?

Time frame: At 8 weeks post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesNo Quit105 Participants
Arm I (Actify, Text Notifications)Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesQuit14 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesNo Quit115 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 30-day PPA From Smoking Cigarettes and Other Non-medicinal Nicotine/Tobacco Products, Including E-cigarettesQuit8 Participants
p-value: 0.1595% CI: [0.77, 4.73]Regression, Logistic
Secondary

Self-reported 7-day PPA From Smoking

Self-reported 7-day abstinence on the survey question of When was the last time you smoked, or even tried, a cigarette?

Time frame: At 6 months post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Self-reported 7-day PPA From SmokingNo Quit95 Participants
Arm I (Actify, Text Notifications)Self-reported 7-day PPA From SmokingQuit24 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 7-day PPA From SmokingNo Quit105 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 7-day PPA From SmokingQuit18 Participants
p-value: 0.2595% CI: [0.75, 2.89]Regression, Logistic
Secondary

Self-reported 7-day PPA From Smoking

Self-reported 7-day abstinence on the survey question of When was the last time you smoked, or even tried, a cigarette?

Time frame: At 8 weeks post-randomization

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Arm I (Actify, Text Notifications)Self-reported 7-day PPA From SmokingNo Quit93 Participants
Arm I (Actify, Text Notifications)Self-reported 7-day PPA From SmokingQuit26 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 7-day PPA From SmokingNo Quit107 Participants
Arm II (Current Standard Care, Text Notifications)Self-reported 7-day PPA From SmokingQuit16 Participants
p-value: 0.0795% CI: [0.94, 3.72]Regression, Logistic

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026